Table I.
Contraindications for Angiotensin Converting Enzyme inhibitor or Angiotensin Receptor Blocker, beta-blockers and anticoagulant therapy
| Performance measure | Contraindication (ICD-9 codes) | Number of patients* |
|---|---|---|
| ACE inhibitor or ARB | Allergy or intolerance (995.0 and E942.9, 995.1 and E942.9, 995.27 and E942.9, 995.29 and E942.9) | N=0 |
| Moderate/severe aortic stenosis (440.1, 395.0, 396.0, 396.2, 396.8, 425.1, 747.22) | N=28 | |
| Previous severe adverse reactions (Angioedema: 995.1 or Anuric renal failure: V56.0, V56.8, 39.95, 54.98, 788.5, 586, 403.01,403.11, 403.91, 404.02,404.03, 404.12, 404.13, 404.92, 404.93, 584.5-584.9, 585.5, 585.6) | N=50 | |
| Pregnancy (V22.0-V23.9) | N=1 | |
| Anticoagulant therapy | Allergy or intolerance (995.0 and E934.2, 995.1 and E934.2, 995.27 and E934.2, 995.29 and E934.2) | N=0 |
| Pregnancy (V22.0-V23.9) | N=0 | |
| Previous gastrointestinal/genitourinary hemorrhage (578.x, 531.0, 531.2, 531.4, 531.6, 532.0, 532.2, 532.4, 532.6, 533.0, 533.2, 533.4, 533.6, 534.0, 534.2, 534.4, 534.6, 535.x1, 530.82, 456.0, 456.2, 569.3, 596.7) | N=67 | |
| Prior intracranial hemorrhage: (430.x, 431.x, 432.0, 432.1, 432.9, 851, 852.xx, 853.xx, 854.xx) | N=8 | |
| Prior other hemorrhage (362.81, 459.0, 786.3) | N=28 | |
| Prior cirrhosis/ hepatitis (070.2-070.9, 570, 571.x, 572.2, 572.3, 572.4, 572.8) | N=21 | |
| Hemorrhagic tendencies or blood dyscrasias (286.0, 286.5, 286.6, 286.7, 286.9, 287.3, 287.4, 287.5, 287.8, 287.9, 289.9) | N=55 | |
| Alcoholism or drug abuse (303.x, 304.x,305.x [excluding 305.1]) | N=8 | |
| Perceived barriers to compliance (295.x-298.x, V60.0-V60.4, V15.81) | N=28 | |
| Predisposition to falls (290.x-294.x. 331.0, 331.1, 333.4, 345.x, 347, 458.0, 780.2, 780.3, E884.2-E884.6, 733.1) | N=67 | |
| Prior cerebral aneurism (407.3) | N=0 | |
| Beta-blockers | Allergy/intolerance (995.0 and E942.9, 995.1 and E942.9, 995.27 and E942.9, 995.29 and E942.9) | N=0 |
| Marked bradycardia Abstracted from ECG (HR<50 bpm) | N=0 | |
| AV block 2nd type 2/ 3rd degree and no pace maker (426.0, 426.12) | N=2 |
*
Contraindications groups were not mutually exclusive, multiple contraindications might be present in the same patient.